The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Fibroblast growth factor signalling: from development to cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Pardo, O. E., Arcaro, A., Salerno, G., Raguz, S., Downward, J., & Seckl, M. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.a115.109006 · Cited by 152
RetractedPardo, O. E., Arcaro, A., Salerno, G., Raguz, S., Downward, J., & Seckl, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109006200 · Cited by 152
RetractedPatterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Marshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906
Regulation of Wound Healing by Growth Factors and Cytokines
WERNER, S., & GROSE, R. (2003) · Physiological Reviews · doi:10.1152/physrev.2003.83.3.835 · Cited by 3,629
Self-citationPatterns of somatic mutation in human cancer genomes
Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,080
Genome-wide association study identifies novel breast cancer susceptibility loci
Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., et al. (2007) · Nature · doi:10.1038/nature05887 · Cited by 2,319
Ornitz, D. M., & Itoh, N. (2001) · Genome biology · doi:10.1186/gb-2001-2-3-reviews3005 · Cited by 2,020
The FGF family: biology, pathophysiology and therapy
Beenken, A., & Mohammadi, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2792 · Cited by 1,945
Cellular signaling by fibroblast growth factor receptors
Eswarakumar, V. P., Lax, I., & Schlessinger, J. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.001 · Cited by 1,929
Receptor Specificity of the Fibroblast Growth Factor Family
Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G., & Goldfarb, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15292 · Cited by 1,871
Stromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Omeroglu, G., Meterissian, S., Omeroglu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,687
Casanovas, O., Hicklin, D. J., Bergers, G., & Hanahan, D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.005 · Cited by 1,621
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K. E., Evans, W. E., O'Riordan, J. L. H., Speer, M. C., Econs, M. J., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. M. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,528
Epithelial-Mesenchymal Transitions
Kang, Y., & Massagué, J. (2004) · Cell · doi:10.1016/j.cell.2004.07.011 · Cited by 1,525
Hunter, D. J., Kraft, P., Jacobs, K. B., Cox, D. G., Yeager, M., Hankinson, S. E., Wacholder, S., Wang, Z., Welch, R., Hutchinson, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2075 · Cited by 1,481
Genome-wide analysis of estrogen receptor binding sites
Carroll, J. S., Meyer, C. A., Song, J., Li, W., Geistlinger, T. R., Eeckhoute, J., Brodsky, A. S., Keeton, E. K., Fertuck, K. C., Hall, G. F., et al. (2006) · Nature Genetics · doi:10.1038/ng1901 · Cited by 1,377
Regulation of Fibroblast Growth Factor-23 Signaling by Klotho
Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Baum, M. G., Schiavi, S., Hu, M.-C., Moe, O. W., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500457200 · Cited by 1,366
Perturbations of the AKT signaling pathway in human cancer
Altomare, D. A., & Testa, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1209085 · Cited by 1,329
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
Presta, M., Dell’Era, P., Mitola, S., Moroni, E., Ronca, R., & Rusnati, M. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.004 · Cited by 1,261
Fgf10 is essential for limb and lung formation
Sekine, K., Ohuchi, H., Fujiwara, M., Yamasaki, M., Yoshizawa, T., Sato, T., Yagishita, N., Matsui, D., Koga, Y., Itoh, N., et al. (1999) · Nature Genetics · doi:10.1038/5096 · Cited by 1,231
Receptor Specificity of the Fibroblast Growth Factor Family
Zhang, X., Ibrahimi, O. A., Olsen, S. K., Umemori, H., Mohammadi, M., & Ornitz, D. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601252200 · Cited by 1,164 · cited 1×
“The specificity of the FGF–FGFR interaction is established partly by the differing ligand-binding capacities of the receptor paralogue”
BackgroundBIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
Hilberg, F., Roth, G. J., Krssak, M., Kautschitsch, S., Sommergruber, W., Tontsch-Grunt, U., Garin-Chesa, P., Bader, G., Zoephel, A., Quant, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6307 · Cited by 1,056
An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination
Meyers, E. N., Lewandoski, M., & Martin, G. R. (1998) · Nature Genetics · doi:10.1038/ng0298-136 · Cited by 1,031
Ornitz, D. M., & Marie, P. J. (2002) · Genes & Development · doi:10.1101/gad.990702 · Cited by 905
Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
Spielberger, R., Stiff, P., Bensinger, W., Gentile, T., Weisdorf, D., Kewalramani, T., Shea, T., Yanovich, S., Hansen, K., Noga, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040125 · Cited by 893
Min, H., Danilenko, D. M., Scully, S. A., Bolon, B., Ring, B. D., Tarpley, J. E., DeRose, M., & Simonet, W. S. (1998) · Genes & Development · doi:10.1101/gad.12.20.3156 · Cited by 879
Kimelman, D., & Kirschner, M. (1987) · Cell · doi:10.1016/0092-8674(87)90110-3 · Cited by 874
Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3
Colvin, J. S., Bohne, B. A., Harding, G. W., McEwen, D. G., & Ornitz, D. M. (1996) · Nature Genetics · doi:10.1038/ng0496-390 · Cited by 873
Moerlooze, L. D., Spencer-Dene, B., Revest, J.-M., Hajihosseini, M., Rosewell, I., & Dickson, C. (2000) · Development · doi:10.1242/dev.127.3.483 · Cited by 864
Relf, M., LeJeune, S., Scott, P. A. E., Fox, S. B., Smith, K. A., Leek, R., Moghaddam, A., Whitehouse, R. M., Bicknell, R., & Harris, A. L. (1997) · PubMed · Cited by 833
Schweigerer, L., Neufeld, G., Friedman, J., Abraham, J. A., Fiddes, J. C., & Gospodarowicz, D. (1987) · Nature · doi:10.1038/325257a0 · Cited by 754
Hacohen, N., Kramer, S., Sutherland, D., Hiromi, Y., & Krasnow, M. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80919-8 · Cited by 749
Structural basis for fibroblast growth factor receptor activation
Mohammadi, M., Olsen, S. K., & Ibrahimi, O. A. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.008 · Cited by 735
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
Cappellen, D., De Oliveira, C., Ricol, D., de Medina, S., Bourdin, J., Sastre-Garau, X., Chopin, D., Thiery, J. P., & Radvanyi, F. (1999) · Nature Genetics · doi:10.1038/12615 · Cited by 713
Mechanisms underlying differential responses to FGF signaling
Dailey, L., Ambrosetti, D., Mansukhani, A., & Basilico, C. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.007 · Cited by 649
Modulation of Epithelial Cell Growth by Intraepithelial γδ T Cells
Boismenu, R., & Havran, W. L. (1994) · Science · doi:10.1126/science.7973709 · Cited by 646
Chesi, M., Nardini, E., Brents, L. A., Schröck, E., Ried, T., Kuehl, W. M., & Bergsagel, P. L. (1997) · Nature Genetics · doi:10.1038/ng0797-260 · Cited by 637
Yu, K., Xu, J., Liu, Z., Sosic, D., Shao, J., Olson, E. N., Towler, D. A., & Ornitz, D. M. (2003) · Development · doi:10.1242/dev.00491 · Cited by 634
Cbl: many adaptations to regulate protein tyrosine kinases
Thien, C. B. F., & Langdon, W. Y. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35067100 · Cited by 625
Arman, E., Haffner-Krausz, R., Chen, Y., Heath, J. K., & Lonai, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5082 · Cited by 617
A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome
Muenke, M., Schell, U., Hehr, A., Robin, N. H., Losken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W., Malcolm, S., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-269 · Cited by 614
The Function of KGF in Morphogenesis of Epithelium and Reepithelialization of Wounds
Werner, S., Smola, H., Liao, X., Longaker, M. T., Krieg, T., Hofschneider, P. H., & Williams, L. T. (1994) · Science · doi:10.1126/science.7973639 · Cited by 604
Male-to-Female Sex Reversal in Mice Lacking Fibroblast Growth Factor 9
Colvin, J. S., Green, R. P., Schmahl, J., Capel, B., & Ornitz, D. M. (2001) · Cell · doi:10.1016/s0092-8674(01)00284-7 · Cited by 588
Clinical Implications of Circulating Angiogenic Factors in Cancer Patients
Poon, R. T.-P., Fan, S.-T., & Wong, J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1207 · Cited by 587
Ensoli, B., Gendelman, R., Markham, P., Fiorelli, V., Colombini, S., Raffeld, M., Cafaro, A., Chang, H.-K., Brady, J. N., & Gallo, R. C. (1994) · Nature · doi:10.1038/371674a0 · Cited by 570
Matsui, J., Yamamoto, Y., Funahashi, Y., Tsuruoka, A., Watanabe, T., Wakabayashi, T., Uenaka, T., & Asada, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23131 · Cited by 551
Kandel, J., Bossy-Wetzel, E., Radvanyi, F., Klagsbrun, M., Folkman, J., & Hanahan, D. (1991) · Cell · doi:10.1016/0092-8674(91)90033-u · Cited by 508
Naski, M. C., Wang, Q., Xu, J., & Ornitz, D. M. (1996) · Nature Genetics · doi:10.1038/ng0696-233 · Cited by 498
Functions and regulations of fibroblast growth factor signaling during embryonic development
Thisse, B., & Thisse, C. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.09.011 · Cited by 497
Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain
Mohammadi, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.20.5896 · Cited by 482
Sprouty, an intracellular inhibitor of Ras signaling
Casci, T., Vinós, J., & Freeman, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80576-0 · Cited by 467
Shimada, T., Urakawa, I., Yamazaki, Y., Hasegawa, H., Hino, R., Yoneya, T., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.102 · Cited by 429
Signal transduction by fibroblast growth factor receptors
Klint, P. (1999) · Frontiers in Bioscience · doi:10.2741/klint · Cited by 424
Peters, K. G., Marie, J., Wilson, E., Ives, H. E., Escobedo, J., Rosario, M. D., Mirda, D., & Williams, L. T. (1992) · Nature · doi:10.1038/358678a0 · Cited by 407
Yan, G., Fukabori, Y., McBride, G., Nikolaropolous, S., & McKeehan, W. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4513 · Cited by 403
Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice
Falardeau, J., Chung, W. C. J., Beenken, A., Raivio, T., Plummer, L., Sidis, Y., Jacobson-Dickman, E. E., Eliseenkova, A. V., Ma, J., Dwyer, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34538 · Cited by 397
Spatial and temporal patterns of ERK signaling during mouse embryogenesis
Corson, L. B., Yamanaka, Y., Lai, K.-M. V., & Rossant, J. (2003) · Development · doi:10.1242/dev.00669 · Cited by 390
Garcia-Closas, M., Hall, P., Nevanlinna, H., Pooley, K., Morrison, J., Richesson, D. A., Bojesen, S. E., Nordestgaard, B. G., Axelsson, C. K., Arias, J. I., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000054 · Cited by 378
A Mouse Model of Hepatocellular Carcinoma
Nicholes, K., Guillet, S., Tomlinson, E., Hillan, K., Wright, B., Frantz, G. D., Pham, T. A., Dillard-Telm, L., Tsai, S. P., Stephan, J.-P., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61177-7 · Cited by 359
The role of fibroblast growth factors and their receptors in prostate cancer
Kwabi-Addo, B., Ozen, M., & Ittmann, M. (2004) · Endocrine-Related Cancer · doi:10.1677/erc.1.00535 · Cited by 350
Drug-sensitive FGFR2 mutations in endometrial carcinoma
Dutt, A., Salvesen, H. B., Chen, T.-H., Ramos, A. H., Onofrio, R. C., Hatton, C., Nicoletti, R., Winckler, W., Grewal, R., Hanna, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803379105 · Cited by 345
FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma
Jebar, A. H., Hurst, C. D., Tomlinson, D. C., Johnston, C., Taylor, C. F., & Knowles, M. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208705 · Cited by 340
FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome
Xiao, S., Nalabolu, S. R., Aster, J. C., Ma, J., Abruzzo, L., Jaffe, E. S., Stone, R., Weissman, S. M., Hudson, T. J., & Fletcher, J. A. (1998) · Nature Genetics · doi:10.1038/ng0198-84 · Cited by 323
Sef is a feedback-induced antagonist of Ras/MAPK-mediated FGF signalling
Fürthauer, M., Lin, W., Ang, S.-L., Thisse, B., & Thisse, C. (2002) · Nature Cell Biology · doi:10.1038/ncb750 · Cited by 312
Acevedo, V. D., Gangula, R. D., Freeman, K. W., Li, R., Zhang, Y., Wang, F., Ayala, G. E., Peterson, L. E., Ittmann, M., & Spencer, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.004 · Cited by 308
Identification of Sef, a novel modulator of FGF signalling
Tsang, M., Friesel, R., Kudoh, T., & Dawid, I. B. (2002) · Nature Cell Biology · doi:10.1038/ncb749 · Cited by 304
Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma
Lin, W. M., Baker, A. C., Beroukhim, R., Winckler, W., Feng, W., Marmion, J. M., Laine, E., Greulich, H., Tseng, H., Gates, C., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2615 · Cited by 297
Chesi, M., Brents, L. A., Ely, S. A., Bais, C., Robbiani, D. F., Mesri, E. A., Kuehl, W. M., & Bergsagel, P. L. (2001) · Blood · doi:10.1182/blood.v97.3.729 · Cited by 289
Wang, Y., & Becker, D. (1997) · Nature Medicine · doi:10.1038/nm0897-887 · Cited by 284
Allele-Specific Up-Regulation of FGFR2 Increases Susceptibility to Breast Cancer
Meyer, K. B., Maia, A.-T., O'Reilly, M., Teschendorff, A. E., Chin, S.-F., Caldas, C., & Ponder, B. A. J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060108 · Cited by 280
Giri, D., Ropiquet, F., & Ittmann, M. (1999) · PubMed · Cited by 280
Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4
Hart, K. C., Robertson, S. C., Kanemitsu, M. Y., Meyer, A. N., Tynan, J. A., & Donoghue, D. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203650 · Cited by 276
Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.
Bange, J., Prechtl, D., Cheburkin, Y. V., Specht, K., Harbeck, N., Schmitt, M., Knyazeva, T., Müller, S., Gärtner, S., Sures, I., et al. (2002) · PubMed · Cited by 275
Jang, J., Shin, K., & Park, J.-G. (2001) · PubMed · Cited by 273
FGFR1 Emerges as a Potential Therapeutic Target for Lobular Breast Carcinomas
Reis-Filho, J. S., Simpson, P. T., Turner, N. C., Lambros, M. B., Jones, C., Mackay, A., Grigoriadis, A., Sarrio, D., Savage, K., Dexter, T., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1164 · Cited by 270
Self-citationFGFR2 -Amplified Gastric Cancer Cell Lines Require FGFR2 and Erbb3 Signaling for Growth and Survival
Kunii, K., Davis, L., Gorenstein, J., Hatch, H., Yashiro, M., Di Bacco, A., Elbi, C., & Lutterbach, B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5229 · Cited by 269
Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins
Gotoh, N. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00840.x · Cited by 268
Desnoyers, L. R., Pai, R., Ferrando, R. E., Hötzel, K., Le, T., Ross, J., Carano, R., D'Souza, A., Qing, J., Mohtashemi, I., et al. (2008) · Oncogene · doi:10.1038/sj.onc.1210623 · Cited by 264
Promotion and Attenuation of FGF Signaling Through the Ras-MAPK Pathway
Tsang, M., & Dawid, I. B. (2004) · Science's STKE · doi:10.1126/stke.2282004pe17 · Cited by 262
Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice
Qing, J., Du, X., Chen, Y., Chan, P., Li, H., Wu, P., Marsters, S., Stawicki, S., Tien, J., Totpal, K., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38017 · Cited by 255
Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer
Platt, F. M., Hurst, C. D., Taylor, C. F., Gregory, W. M., Harnden, P., & Knowles, M. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0898 · Cited by 251
Aman, A., & Piotrowski, T. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.10.002 · Cited by 249
Yamaguchi, F., Saya, H., Bruner, J. M., & Morrison, R. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.484 · Cited by 245
Courjal, F., Cuny, M., Simony-Lafontaine, J., Louason, G., Speiser, P., Zeillinger, R., Rodríguez, C., & Theillet, C. G. (1997) · PubMed · Cited by 238
A secreted FGF-binding protein can serve as the angiogenic switch in human cancer
Czubayko, F., Liaudet-Coopman, E. D. E., Aigner, A., Tuveson, A. T., Berchem, G. J., & Wellstein, A. (1997) · Nature Medicine · doi:10.1038/nm1097-1137 · Cited by 237
Mosaicism of activatingFGFR3 mutations in human skin causes epidermal nevi
Hafner, C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28163 · Cited by 227
Marek, L., Ware, K. E., Fritzsche, A., Hercule, P., Helton, W. R., Smith, J. E., McDermott, L. A., Coldren, C. D., Nemenoff, R. A., Merrick, D. T., et al. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.049544 · Cited by 222
López-Knowles, E., Hernández, S., Malats, N., Kogevinas, M., Lloreta, J., Carrato, A., Tardón, A., Serra, C., Real, F. X., & EPICURO Study Group Investigators (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1182 · Cited by 218
Prostatic growth and development are regulated by FGF10
Thomson, A. A., & Cunha, G. R. (1999) · Development · doi:10.1242/dev.126.16.3693 · Cited by 206
Goriely, A., Hansen, R. M. S., Taylor, I. B., Olesen, I. A., Jacobsen, G. K., McGowan, S. J., Pfeifer, S. P., McVean, G. A. T., Meyts, E. R.-D., & Wilkie, A. O. M. (2009) · Nature Genetics · doi:10.1038/ng.470 · Cited by 205
Memarzadeh, S., Xin, L., Mulholland, D. J., Mansukhani, A., Wu, H., Teitell, M. A., & Witte, O. N. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.002 · Cited by 201
Avet‐Loiseau, H., Facon, T. T. F., Daviet, A., Godon, C., Rapp, M.-J., Harousseau, J., Grosbois, B., & Bataille, R. (1999) · PubMed · Cited by 194
Regulation of G1 cell-cycle progression by oncogenes and tumor suppressor genes
Ho, A. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00263-5 · Cited by 192
MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways
Callahan, R., & Smith, G. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203276 · Cited by 184
Pardo, O. E., Wellbrock, C., Khanzada, U. K., Aubert, M., Arozarena, I., Davidson, S., Bowen, F., Parker, P. J., Filonenko, V. V., Gout, I. T., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601198 · Cited by 183
Logié, A., Dunois-Lardé, C., Rosty, C., Levrel, O., Blanche, M., Ribeiro, A., Gasc, J.-M., Jorcano, J., Werner, S., Sastre-Garau, X., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi127 · Cited by 181
The heparanome and regulation of cell function: structures, functions and challenges
Ori, A. (2008) · Frontiers in Bioscience · doi:10.2741/3007 · Cited by 177
Avet‐Loiseau, H., Li, J., Facon, T. T. F., Brigaudeau, C., Morineau, N., Maloisel, F., Rapp, M.-J., Talmant, P., Trimoreau, F., Jaccard, A., et al. (1998) · PubMed · Cited by 177
Zhao, Y., & Zhang, Z.-Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103369200 · Cited by 175
Lopez-Knowles, E., Hernandez, S., Malats, N., Kogevinas, M., Lloreta, J., Carrato, A., Tardon, A., Serra, C., & Real, F. X. (2006) · European Urology Supplements · doi:10.1016/s1569-9056(06)61338-9 · Cited by 173
Schaeffer, E. M., Marchionni, L., Huang, Z., Simons, B., Blackman, A., Yu, W., Parmigiani, G., & Berman, D. M. (2008) · Oncogene · doi:10.1038/onc.2008.327 · Cited by 172
Gorringe, K. L., Jacobs, S., Thompson, E. R., Sridhar, A., Qiu, W., Choong, D. Y. H., & Campbell, I. G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0502 · Cited by 171
Freier, K., Schwaenen, C., Sticht, C., Flechtenmacher, C., Mühling, J., Hofele, C., Radlwimmer, B., Lichter, P., & Joos, S. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2006.01.005 · Cited by 165
FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo
Clark, J. C., Tichelaar, J. W., Wert, S. E., Itoh, N., Perl, A.-K. T., Stahlman, M. T., & Whitsett, J. A. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.4.l705 · Cited by 165
Birrer, M., Johnson, M. E., Hao, K., Wong, K. K., Park, D., Bell, A., Welch, W., Berkowitz, R., & Mok, S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0795 · Cited by 165
A 1 Mb minimal amplicon at 8p11–12 in breast cancer identifies new candidate oncogenes
Garcia, M. J., Pole, J. C. M., Chin, S.-F., Teschendorff, A., Naderi, A., Ozdag, H., Vias, M., Kranjac, T., Subkhankulova, T., Paish, C., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208741 · Cited by 164
Characterization of a Novel Protein (FGFRL1) from Human Cartilage Related to FGF Receptors
Wiedemann, M., & Trueb, B. (2000) · Genomics · doi:10.1006/geno.2000.6332 · Cited by 163
Simon, R., Richter, J., Wagner, U. A., Fijan, A., Bruderer, J., Schmid, U., Ackermann, D., Maurer, R. E., Alund, G., Knönagel, H., et al. (2001) · PubMed · Cited by 162
Lauring, J. D., Abukhdeir, A. M., Konishi, H., Garay, J. P., Gustin, J. P., Wang, Q., Arceci, R. J., Matsui, W. H., & Park, B. H. (2007) · Blood · doi:10.1182/blood-2007-05-088674 · Cited by 162
Koziczak, M., Holbro, T., & Hynes, N. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207331 · Cited by 160
van Rhijn, B. V., van Tilborg, A. V., Lurkin, I., Bonaventure, J., de Vries, A., Thiery, J., van der Kwast, T., Zwarthoff, E., & Radvanyi, F. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200883 · Cited by 155
Roumiantsev, S., Krause, D. S., Neumann, C. A., Dimitri, C. A., Asiedu, F., Cross, N. C. P., & Etten, R. A. V. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00053-4 · Cited by 152
FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer
Nomura, S., Yoshitomi, H., Takano, S., Shida, T., Kobayashi, S., Ohtsuka, M., Kimura, F., Shimizu, H., Yoshidome, H., Kato, A., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604473 · Cited by 152
LADD syndrome is caused by FGF10 mutations
Milunsky, J., Zhao, G., Maher, T. A., Colby, R., & Everman, D. (2006) · Clinical Genetics · doi:10.1111/j.1399-0004.2006.00597.x · Cited by 151
Byron, S. A., Gartside, M. G., Wellens, C. L., Mallon, M. A., Keenan, J. B., Powell, M. A., Goodfellow, P. J., & Pollock, P. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0770 · Cited by 149
Nuclear Translocation of Cell‐Surface Receptors: Lessons from Fibroblast Growth Factor
Bryant, D. M., & Stow, J. (2005) · Traffic : the International Journal of Intracellular Transport · doi:10.1111/j.1600-0854.2005.00332.x · Cited by 145
Inducible dimerization of FGFR1
Welm, B. E., Freeman, K. W., Chen, M., Contreras, A., Spencer, D. M., & Rosen, J. M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200107119 · Cited by 145
Xian, W., Schwertfeger, K. L., Vargo-Gogola, T. C., & Rosen, J. M. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505098 · Cited by 144
Maher, P. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17491 · Cited by 144
Fibroblast growth factor blocks Sonic hedgehog signaling in neuronal precursors and tumor cells
Fogarty, M. P., Emmenegger, B. A., Grasfeder, L. L., Oliver, T. G., & Wechsler‐Reya, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605770104 · Cited by 143
The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells
Trudel, S., Stewart, A. K., Rom, E., Wei, E. N., Li, Z. H., Kotzer, S., Chumakov, I., Singer, Y., Chang, H., Liang, S., et al. (2006) · Blood · doi:10.1182/blood-2005-10-4179 · Cited by 143
Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1
Vainikka, S., Joukov, V., Wennström, S., Bergman, M., Pelicci, P. G., & Alitalo, K. K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32309-8 · Cited by 141
Wu, D. Q., Kan, M. K., SATO, G. H., Okamoto, T., & Sato, J. D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55368-0 · Cited by 138
Sarker, D., Molife, R., Evans, T. R. J., Hardie, M., Marriott, C., Bützberger, P., Morrison, R., Fox, J. A., Heise, C. C., Louie, S. G., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1466 · Cited by 138
Tomlinson, D. C., Lamont, F. R., Shnyder, S. D., & Knowles, M. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2816 · Cited by 138
Takeda, M., Arao, T., Yokote, H., Komatsu, T., Yanagihara, K., Sasaki, H., Yamada, Y., Tamura, T., Fukuoka, K., Kimurâ, H., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2743 · Cited by 136
Peters, G. G., Lee, A. E., & Dickson, C. (1986) · Nature · doi:10.1038/320628a0 · Cited by 134
Savagner, P., Vallés, A. M., Jouanneau, J., Yamada, K. M., & Thiery, J. P. (1994) · Molecular Biology of the Cell · doi:10.1091/mbc.5.8.851 · Cited by 133
FGFR4 Arg388 Allele Is Associated With Resistance to Adjuvant Therapy in Primary Breast Cancer
Thussbas, C., Nährig, J., Streit, S., Bange, J., Kriner, M., Kates, R. E., Ulm, K., Kiechle, M. B., Hoefler, H., Ullrich, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.8587 · Cited by 131
The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development
Grose, R. P., Fantl, V., Werner, S., Chioni, A., Jarosz, M., Rudling, R. J., Cross, B., Hart, I. R., & Dickson, C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601583 · Cited by 128
Self-citationTyrosine kinase fusion genes in chronic myeloproliferative diseases
Cross, N. C. P., & Reiter, A. (2002) · Leukemia · doi:10.1038/sj.leu.2402556 · Cited by 126
Keller, U. A. D., Huber, M., Beyer, T. A., Kümin, A., Siemes, C., Braun, S., Bugnon, P., Mitropoulos, V., Johnson, D. A., Johnson, J. A., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.10.3773-3784.2006 · Cited by 125
Inhibition of Fibroblast Growth Factor 19 Reduces Tumor Growth by Modulating β-Catenin Signaling
Pai, R., Dunlap, D. Y., Qing, J., Mohtashemi, I., Hötzel, K., & French, D. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2325 · Cited by 125
Tekin, M., Hismi, B., Fitoz, S., Özdağ, H., Cengiz, F., Sırmacı, A., Aslan, I., Inceoğlu, B., Yüksel-Konuk, E. B., Yilmaz, S., et al. (2007) · American Journal of Human Genetics · doi:10.1086/510920 · Cited by 123
Raucci, A., Laplantine, E., Mansukhani, A., & Basilico, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310384200 · Cited by 121
Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
Gartside, M. G., Chen, H., Ibrahimi, O. A., Byron, S. A., Curtis, A. V., Wellens, C. L., Bengston, A., Yudt, L. M., Eliseenkova, A. V., Ma, J., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0021 · Cited by 121
Martínez-Torrecuadrada, J., Cifuentes, G., Lopez-Serra, P., Sáenz, P., Martínez, A., & Casal, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0282 · Cited by 118
Fox-2 Mediates Epithelial Cell-Specific Fibroblast Growth Factor Receptor 2 Exon Choice
Baraniak, A. P., Chen, J. R., & García-Blanco, M. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1209-1222.2006 · Cited by 118
Harmer, N. J., Ilag, L. L., Mulloy, B., Pellegrini, L., Robinson, C. V., & Blundell, T. L. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.04.031 · Cited by 109
di Martino, E., L’Hôte, C., Kennedy, W., Tomlinson, D. C., & Knowles, M. A. (2009) · Oncogene · doi:10.1038/onc.2009.280 · Cited by 108
Missiaglia, E., Selfe, J., Hamdi, M., Williamson, D., Schaaf, G., Fang, C., Köster, J., Summersgill, B. M., Messahel, B., Versteeg, R., et al. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20655 · Cited by 108
Pardo, O. E., Lesay, A., Arcaro, A., Lopes, R., Ng, B. L., Warne, P. H., McNeish, I. A., Tetley, T. D., Lemoine, N. R., Mehmet, H., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7600-7610.2003 · Cited by 107
Bernard‐Pierrot, I., Gruel, N., Stransky, N., Vincent‐Salomon, A., Reyal, F., Raynal, V., Vallot, C., Pierron, G., Radvanyi, F., & Delattre, O. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1360 · Cited by 103
Li, Z.-H., Zhu, Y.-X., Plowright, E. E., Bergsagel, P., Chesi, M., Patterson, B., Hawley, T., Hawley, R. G., & Stewart, A. K. (2001) · Blood · doi:10.1182/blood.v97.8.2413 · Cited by 100
Sun, H. D., Malabunga, M., Tonra, J. R., DiRenzo, R., Carrick, F. E., Zheng, H., Berthoud, H., McGuinness, O. P., Shen, J., Böhlen, P., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00089.2006 · Cited by 97
Ropiquet, F., Giri, D., Kwabi‐Addo, B., Mansukhani, A., & Ittmann, M. (2000) · PubMed · Cited by 94
Zhang, Y., Wang, H., Toratani, S., Sato, J., Kan, M., McKeehan, W. L., & Okamoto, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191377098 · Cited by 94
FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies
Chen, J., Lee, B. H., Williams, I. R., Kutok, J. L., Mitsiades, C. S., Duclos, N., Cohen, S., Adelsperger, J., Okabe, R. O., Coburn, A., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208989 · Cited by 92
Yagasaki, F., Wakao, D., Yokoyama, Y., Uchida, Y., MUROHASHI, I., Kayano, H., Taniwaki, M., Matsuda, A., & Bessho, M. (2001) · PubMed · Cited by 92
Cha, J. Y., Maddileti, S., Mitin, N., Harden, T. K., & Der, C. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803998200 · Cited by 87
Expression of the FGFR1 gene in human breast‐carcinoma cells
Jacquemier, J. D., Adélaı̈de, J., Parc, P., Penault-Llorca, F. M., Planche, J., deLapeyrière, O., & Birnbaum, D. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590314 · Cited by 86
Freeman, K. W., Welm, B. E., Gangula, R., Rosen, J. M., Ittmann, M., Greenberg, N. M., & Spencer, D. M. (2003) · PubMed · Cited by 82
Freeman, K. W., Gangula, R., Welm, B. E., Özen, M., Foster, B. A., Rosen, J. M., Ittmann, M., Greenberg, N. M., & Spencer, D. M. (2003) · PubMed · Cited by 81
Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma
Fritzsche, S., Kenzelmann, M., Hoffmann, M. J., et al. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01190 · Cited by 81
Clinical and biological characteristics of cervical neoplasias with FGFR3 mutation.
Rosty, C., Aubriot‐Lorton, M., Cappellen, D., Bourdin, J., Cartier, I., Thiery, J. P., Sastre‐Garau, X., & Radvanyi, F. (2005) · Molecular Cancer · doi:10.1186/1476-4598-4-15 · Cited by 76
Jackson, D., Bresnick, J. N., Rosewell, I. R., Crafton, T., Poulsom, R., Stamp, G., & Dickson, C. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.11.1261 · Cited by 76
FGFR3 mutations in prostate cancer: association with low-grade tumors
Hernandez, S. F., de Muga, S., Agell, L., Juanpere-Rodero, N., Esgueva, R., Lorente, J. A., Mojal, S., Serrano, S., & Lloreta, J. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.46 · Cited by 75
Presta, M., Tiberio, L., Rusnati, M., Dell’Era, P., & Ragnotti, G. (1991) · Cell Regulation · doi:10.1091/mbc.2.9.719 · Cited by 73
Xian, W., Pappas, L., Pandya, D., Selfors, L. M., Derksen, P. W. B., de Bruin, M., Gray, N. S., Jonkers, J., Rosen, J. M., & Brugge, J. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3398 · Cited by 73
Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma
Nord, H., Segersten, U., Sandgren, J., Wester, K., Busch, C., Menzel, U., Komorowski, J., Dumanski, J. P., Malmström, P., & de Ståhl, T. D. (2009) · International Journal of Cancer · doi:10.1002/ijc.24954 · Cited by 70
Cooperation between FGF8b Overexpression and PTEN Deficiency in Prostate Tumorigenesis
Zhong, C., Saribekyan, G., Liao, C., Cohen, M. B., & Roy‐Burman, P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3440 · Cited by 70
Xian, W., Schwertfeger, K. L., & Rosen, J. M. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0518 · Cited by 70
Daphna-Iken, D., Shankar, D. B., Lawshé, A., Ornitz, D. M., Shackleford, G. M., & MacArthur, C. A. (1998) · Oncogene · doi:10.1038/sj.onc.1202212 · Cited by 67
Zhang, Y., Zhang, J., Lin, Y., Lan, Y., Lin, C., Xuan, J. W., Shen, M. M., McKeehan, W. L., Greenberg, N. M., & Wang, F. (2008) · Development · doi:10.1242/dev.009910 · Cited by 66
Mandinova, A., Kolev, V. N., Neel, V., Hu, B., Stonely, W., Lieb, J., Wu, X., Colli, C., Han, R., Pazin, M. J., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38543 · Cited by 63
Vékony, H., Ylstra, B., Wilting, S. M., Meijer, G. A., van de Wiel, M. A., Leemans, C. R., van der Waal, I., & Bloemena, E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2555 · Cited by 63
Kang, S., Elf, S., Dong, S., Hitosugi, T., Lythgoe, K., Guo, A., Ruan, H., Lonial, S., Khoury, H. J., Williams, I. R., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00998-08 · Cited by 60
Otsuki, T., Yamada, O., Yata, K., Sakaguchi, H., Kurebayashi, J., Nakazawa, N., Taniwaki, M., Yawata, Y., & Ueki, A. (1999) · International Journal of Oncology · doi:10.3892/ijo.15.6.1205 · Cited by 58
Kerbel, R. S. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.016 · Cited by 57
Darby, S., Sahadevan, K., Khan, M. M., Robson, C. N., Leung, H. Y., & Gnanapragasam, V. J. (2006) · Oncogene · doi:10.1038/sj.onc.1209428 · Cited by 57
Fibroblast growth factor receptor signaling through MEK–ERK is required for prostate bud induction
Kuslak, S. L., & Marker, P. C. (2007) · Differentiation · doi:10.1111/j.1432-0436.2006.00161.x · Cited by 52
Landgren, E., Klint, P., Yokote, K., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201936 · Cited by 51
Winter, S. F., Acevedo, V. D., Gangula, R., Freeman, K. W., Spencer, D. M., & Greenberg, N. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210288 · Cited by 48
Characterization of the Intronic Splicing Silencers Flanking FGFR2 Exon IIIb
Wagner, E. J., Baraniak, A. P., Sessions, O. M., Mauger, D., Moskowitz, E. J., & García-Blanco, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414492200 · Cited by 44
町田, 静., Saga, Y., Takei, Y., Mizuno, I., Takayama, T., Kohno, T., Konno, R., Ohwada, M., & Suzuki, M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20751 · Cited by 42
A Crucial Role for Fibroblast Growth Factor Signaling in Embryonic Mammary Gland Development
Dillon, C., Spencer‐Dene, B., & Dickson, C. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000037163.56461.1e · Cited by 39
FGF Signaling in Prostate Tumorigenesis—New Insights into Epithelial-Stromal Interactions
Abate-Shen, C. T., & Shen, M. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.021 · Cited by 39
Fibroblast Growth Factors and Their Receptors in Transitional Cell Carcinoma
Munro, N. P., & Knowles, M. A. (2003) · The Journal of Urology · doi:10.1016/s0022-5347(05)63991-2 · Cited by 38
Identification of an Intronic Splicing Enhancer Essential for the Inclusion of FGFR2 Exon IIIc
Seth, P., Miller, H. B., Lasda, E. L., Pearson, J. L., & García-Blanco, M. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800087200 · Cited by 18
FP-1039 (FGFR1:Fc), a soluble FGFR1 receptor antagonist, inhibits tumor growth and angiogenesis
Zhang, H., Lorianne, M., Baker, K. P., Sadra, A., Bosch, E., Brennan, T., Doberstein, S. K., Goodworth, G., Hestir, K., Hollenbaugh, D. L., et al. (2007) · Molecular Cancer Therapeutics · Cited by 14
Cited by
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
The Fibroblast Growth Factor signaling pathway
Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050
Tumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 1,986
Stem cells: past, present, and future
Zakrzewski, W., Dobrzyński, M., Szymonowicz, M., & Rybak, Z. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1165-5 · Cited by 1,834
Macrophage Polarization States in the Tumor Microenvironment
Boutilier, A. J., & Elsawa, S. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136995 · Cited by 1,631
Metadata
- Authors
- Turner, N., & Grose, R.
- Venue
- Nature Reviews Cancer
- Published
- 2010-02
- Volume
- 10
- Issue
- 2
- Pages
- 116-129
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1988476050
- Cited by
- 2,693
- References
- 181
- FWCI
- 7.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.